Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
EmailIphone Application    Posted: 25th June 2019
If you would like to forward this story on to a friend, simply fill in the form below and click send.
Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Recall issued due to product defect
Particulates were found in some batches of Alfaxan and Alfaxan Multidose 10mg/ml Solution for Injection.

Specific batches of Alfaxan and Alfaxan Multidose affected

The Veterinary Medicines Directorate (VMD) is making vets and wholesalers aware that certain batches of Alfaxan and Alfaxan Multidose 10mg/ml Solution for Injection has been recalled.

Jurox UK issued a recall of specific batches after particulates were found during routine stability testing.

The manufacturer is contacting wholesalers and vets to urge them to examine their inventory immediately and quarantine any recalled products.

Affected batches are:

Batch No. Description Vm Number Pack Size Expiry
55523 Alfaxan Multidose 10 mg/ml Solution for injection for dogs, cats and pet rabbits Vm 25296/4004 10 ml 16/04/21
48317 Alfaxan 10 mg/ml Solution for injection for dogs, cats and pet rabbits Vm 25296/4003 10 ml 22/01/23
62816 Alfaxan 10 mg/ml Solution for injection for dogs, cats and pet rabbits Vm 25296/4003 10 ml 16/07/23

 

 

All other batches and the 20ml pack size are not affected by the recall.
For more information, contact Richard Beckwith on 07584 099536 or richard.beckwith@jurox.co.uk

Become a member or log in to add this story to your CPD history

Annual submission deadline small pet animal exemptions

News Story 1
 Companies marketing medicines for small pets exempt from authorisation must submit their annual return to the Veterinary Medicines Directorate (VMD) by 30 November 2026.

Submitting this annual return ensures continued compliance with regulatory requirements for products marketed without a full Marketing Authorisation. The exemption specifically applies to products intended for animals, cage birds, terrarium animals, small rodents, ferrets and rabbits.

For further details and submission guidelines, visit the gov.uk website.  

Click here for more...
News Shorts
BVA urges 'continued vigilance' over bluetongue

The British Veterinary Association (BVA) has urged vigilance following a concerning rise in Bluetongue (BTV) cases in sheep and cattle.

In a recent statement, the BVA noted that members are reporting more severe clinical signs and higher mortality rates than in previous years.

'We know that farm vets are working hard to support farmers and animals affected by this outbreak, during what is an extremely difficult time for all involved,' they stated. 'Continued vigilance to identify disease early is vital and vaccination remains the best way of protecting animals from this disease.'